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ABSTRACT  
This research focuses on presenting an empirical method to gather necessary data and then developing several models to 
predict the chance of diabetic retinopathy (proliferative and non-proliferative) by observing HbA1c, duration of disease and 
albumin excretion rate of diabetic patients. We gathered required knowledge from other studies that have investigated the 
relation of different risk factors and complications in diabetes. In order to create 1-1 models, curve fitting was performed by 
using two different software applications: Tiberius (Brierley 2011)  and SPSS (IBM 2010),  which work based on ANN and 
least square regression, respectively. To start producing the model, seven different patterns, i.e. linear, logarithmic, quadratic, 
cubic, power, s and exponential, have been chosen as the best regression options. Using R-squared, it can be clearly seen that 
the best selected regression models fit the data in all the dataset tables better than ANN, as well as the other six regression 
patterns. 
Keywords  
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INTRODUCTION 
Early and appropriate intervention in diabetes is able to reduce the rate of complications, to prolong life expectancy and to 
reduce the financial cost  (Habacher, Rakovac, Gorzer, Haas, Gfrerer, Wach and Pieber, 2007) . Since there is no simple 
relation between risk factors and their associated complications, predictive modeling can help to make models for forecasting 
future disease behavior based on current observations. In this research we developed a set of models by using the results of 
the previous studies and applying a novel combination of different techniques. The implementation of the published 
Guidelines for Diabetes Care  recommends optimal management and the early detection of existing complications to reduce 
further disease progression (European Diabetes Policy 1999). Many aspects of diabetes complications can be limited or even 
prevented in some instances, with appropriate management of the condition (Huang, McCullagh, Black and Harper, 2007). 
This benefits the patients as well as having the potential to reduce the overall healthcare expenditures. Diabetic retinopathy is 
a complication of diabetes that damages the blood vessels in the eye. There are two main types of diabetic retinopathy: non-
proliferative and proliferative. Early detection and proper treatment of diabetes can prevent up to 90% of blindness, (Boulton 
and Vileikyte, 2000). These complications can be prevented only if the treatment starts before the development of non-
reversible clinical symptoms. This means that being able to predict such complications is essential in order to intervene 
successfully. 
There is a very intricate relationship between diabetic risk factors and their related complications. In order to overcome the 
complexities of this interrelated network, we need to use modeling techniques to simulate the relationships and to break down 
the ultimate model into three simpler steps including modeling the relation between one risk factor and one complication 
(step 1), modeling the relation between all risk factors related to one complication (step 2) and then modeling the relation 
between all risk factors and all complications (step 3).  
In this research we developed a set of models by using observations recorded between HbA1c, duration of disease and 
albumin exertion rate (AER) as selected risk factors and PDR and NPDR as two complications . 
The contribution of this research is: 
Sangi et al.  Model development for prediction of diabetic retinopathy 
 
Proceedings of the Nineteenth Americas Conference on Information Systems, Chicago, Illinois, August 15-17, 2013. 2 
• The development of a method to gather and standardize the knowledge from other research and make a structured format 
for it. 
• The application of two important data mining methods, namely ANN and regression analysis, in order to create a predictive 
model to indicate the relationship between individual risk factors and complications. 
• Measurement of the prediction power of the created models using R-squared, F-ratio and adjusted R-squared equations. 
METHODOLOGY 
Diabetes and its complications were gathered from peer reviewed publications on clinical trials, meta-analysis and the 
Cochrane review from Medline, Cinahl, federated database searches and diabetes management guidelines published from 
1981 to 2012.  All titles of result articles were examined by the research team independently and rated each paper as 
‘potentially relevant’, ‘of doubtful relevance’ or ‘not relevant’. Then the process was repeated for the first two groups by 
reviewing the abstracts and then the full-text versions and all ‘not relevant’ studies were omitted from this research. 
Afterwards these were coded in Nvivo8. In brief, both chronic diabetes complications and diabetes predisposing factors have 
been classified hierarchically by 27 and 47 nodes, respectively. The two are connected by 126 relationships, categorized into 
three different types, namely ‘is a cause for’, ‘prevent from or decrease’ and ‘are the same’. All these nodes and relationships 
are supported by more than 590 identified facts from 99 different sources. Having scanned the abstract of nearly 550 
primitive results, about 140 of the most probably related subjects have been chosen, thus enabling us to use and follow up the 
data of more than 300,000 patient/years (Sangi, Win and Fulcher, 2010). 
Data Conversion was conducted to identify a relationship between one specific risk factor and one complication. Data 
expressions were paraphrased into a ‘from-to’ table record format to indicate that the research has independently studied the 
relation between factors and complications. In other words, these tables are designed in a three-dimensional format in order 
to make data as clear as possible, but later on would be used as two-dimensional records. This format shows by how much 
the probability of a specific complication will change, if, independent of all other factors, the value of a specific risk factor 
changes.  
Some studies express their observations exactly in our desired format. For instance, according to the DCCT research group 
(DCCT 1996), ‘A reduction in HbA1c from 11 to 9.9% yields a reduction in risk of retinopathy progression from 10.78 to 
4.21 cases per 100 patient-years. In contrast, a reduction from 8 to 7.2% yields a reduction in risk from 2.43 to 1.48 cases per 
100 patient-years’. Each of these rates per 100 patient-years is in fact the percentage of retinopathy risk in one year. Although 
some research studies have independently examined the relationship between each risk factor and complication, in order to be 
comparable, the studies must have examined data from patients suffering from the same duration of the disease to be able to 
compare them. So, in this study we calculate the magnitude of absolute risks for a 5-year time period. According to Bulmer 
(Bulmer 1979)  and Johnson (Johnson and Bhattacharyya, 2010),  the probability of risk during ‘n’ years can be estimated by 
addition law since the probability of the risk in one  year is known: 
 	 
    2  

  3  
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     

 
where 
 and  are the probability of risk in the period of one  and n years, respectively. Thus, the above 
sentence can be converted into the desired record format as shown in Table 1. 
 
HbA1c 
 
Retinopathy 
From To From To 
11% 9.9%  43.5% 19.3% 
8% 7.2%  11.6% 7.1% 
Table 1. Risk of retinopathy is changing based on changes in HbA1c levels 
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Most of the studies, however, express their results in other formats .They report only the factor of change in severity 
occurring in a complication, but the absolute amount of probability for the complication is not known.  As the DCCT 
research group (DCCT 2000) writes: ‘as the HbA1c value increased from 8.1 to 10.1 percent, the odds of retinopathy 
increased by a factor of 2.8, but as the value increased from 6.1 to 8.0 percent, the odds were increased by a factor of 2.6’. In 
such cases, by having the risk percentage of the first point, the risk percentage of other points would be calculated easily as 
the factors of change are available. There are other studies which indicate the risk of complications in another format. For 
example, ‘Patients whose intensive insulin therapy resulted in HbA1c levels 2% lower than those receiving conventional 
insulin therapy had a 76% lower incidence of retinopathy’ (Brownlee, Aiello, Cooper, Vinik, Nesto and Boulton 2011). 
Similarly, as long as the absolute risk of retinopathy in conventional therapy is available, the risk percentage for the intensive 
therapy group would be calculated. In this case, the mean amounts of HbA1c in conventional and intensive therapy are nearly 
7.2% and 9.1%, respectively. Finally, some studies demonstrate the changes in graphical representations, but the data from 
these needed to be extracted and presented in the format we needed. As mentioned above, the reason we chose the ‘from-to’ 
format was to take into consideration the fact that the research has independently studied the relation between factors and 
complications, but here we use them as two-dimensional records. Table 2, as an example, shows a dataset of the relation 
between HbA1c and non-proliferative diabetic retinopathy (NPDR). 
 
HbA1c 
level 6.8 6.95 7.85 7.95 8 8.95 9.2 9.5 9.9 9.95 10.5 10.55 11.7 12 
Risk of 
NPDR 14.5 3 20 3.8 14 7.1 27 20 27 7.9 9.9 28 51 32 
Table 2. A dataset showing the relation between HbA1c and non-proliferative diabetic retinopathy 
 
Model Validation 
Evaluate of Gathered Data 
One of the disadvantages of secondary data is that the user has no control over their accuracy. Although timely and pertinent 
secondary data may fit the researcher’s requirements, the data could be inaccurate. Research conducted by other persons may 
be biased to support the vested interest of the source. If the possibility of bias exists, the secondary data should not be used. If 
the accuracy of the data cannot be established, the researcher must determine whether using the data is worth the risk. 
We accepted data from reliable studies such as DCCT (The Diabetes Control and Complications Trial and Follow-up Study) 
and UKPDS (The United Kingdom Prospective Diabetes Study). Nevertheless, we assessed the reputation of the journals or 
conferences which have published the data and finally we have done cross-checks of data, that is, the comparison of data 
from one source with data from another source to determine the similarity of independent projects. 
Model Comparison and Testing 
The accuracy of a predictor refers to how well a given predictor can guess the value of the predicted attribute for new or 
previously unseen data. There are two important questions to ask: 1) how well does the model fit the observed data and 2) 
can the model generalize to other samples? These questions have been tested by R square, adjusted R square and F test. 
Using the mean as a model, we can calculate the difference between the observed values and the values predicted by the 
mean. This sum of squared differences is known as the ‘total sum of squares’ (SST). This value represents how good the 
mean is as a model of the observed data. Now, if we fit the more sophisticated model to the data, such as a line of best fit, we 
can again work out the differences between this new model and the observed data. The result is known as ‘residual sum of 
squares’ (SSR). The improvement in prediction resulting from using the predictive model rather than the mean is calculated 
by computing the difference between SST and SSR. This difference shows us the reduction in the inaccuracy of the model 
resulting from fitting the predictive model to the data. This improvement is the ‘model sum of squares’ (SSM). A useful 
measure arising from these sums of squares is the proportion of improvement due to the model. This is easily calculated by 
dividing the sum of squares for the model by the total sum of squares. The resulting value is called R2: 
SSM (Model Sum of squares) = SST ((Total Sum Square) - SSR (Residual Sum of Square) 
  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A second assessing the model is through the F-test. F is based upon the ratio of the improvement due to the model (SSM) and 
the difference between the model and the observed data (SSR). Actually, because the sums of squares depend on the number 
of differences that we have added up, we use the average sums of squares (‘mean squares’ or MS). To work out the mean 
sums of squares we divide by the degrees of freedom. For SSM the degrees of freedom are simply the number of variables in 
the model, and for SSR they are the number of observations minus the number of parameters being estimated. The result is the 
mean squares for the model (MSM) and the residual mean squares (MSR). 
    !  
It is important to know F-ratio tells us how much variability the model can explain relative to how much it can’t explain. A 
good model should have a large F-ratio (greater than 1 at least).  
As a second part of this step, we have to assess how well our model can predict the outcome in a different sample. To test 
whether the model does generalize we can look at cross-validating it. Assessing the accuracy of a model across different 
samples is known as cross-validation. In this research, not only are the values of R2 calculated, but also an adjusted R2. This 
adjusted value indicates the loss of predictive power or ‘shrinkage’. Whereas R2 tells us how much of the variance in Y is 
accounted for by the predictive model from our sample, the adjusted value tells us how much variance in Y would be 
accounted for if the model had been derived from the population from which the sample was taken. SPSS derives the 
adjusted R2 using Wherry’s equation (Field 2009). This equation, however, has been criticized because it tells us nothing 
about how well the regression model would predict an entirely different set of data. One version of adjusted R2 that does tell 
us how well the model cross-validates uses Stein’s formula (Stevensand NetLibrary, 2002) which is: 
"#$%&'#   1  *+   1    1, +
  2
    2, +
  1
 ,- 1   
In Stein’s equation, R2 is the unadjusted value, n is the number of participants and k is the number of predictors in the model. 
In addition, there is an independent errors assumption in regression, which means for any two observations the residual terms 
should be uncorrelated (or independent). This eventuality is sometimes described as a lack of ‘autocorrelation’. This 
assumption can be tested with the ‘Durbin–Watson’ test, which tests for serial correlations between errors. The test statistic 
can vary between 0 and 4 with a value of 2 meaning that the residuals are uncorrelated. As a rough rule, the results between 
1.5 and 2.5 imply independent errors (Hutcheson and Sofroniou, 1999). 
Model Structure for Prediction 
ANN and Regression Analysis are two common techniques for making a predictive model based on observed data ((Razi and 
Athappilly, 2005; Smith and  Mason, 1997).  
ANNs can be trained to predict numerical values, and allows the systems to learn from past experiences and recognizes 
patterns in the gathered data. The ANN takes a dataset and tries to combine the 'inputs' (HbA1c value) in such a way to 
model the 'output' (Risk percentage of retinopathy). These models can then be used on new data to predict what the output is 
likely to be for a given set of inputs. The ANN is used as it works more efficiently when a large amounts of data is available 
(Griffith 2000; Lawrence 1994).  
Statistical regression analysis is widely used to estimate different types of functions including linear, polynomial, 
exponential, and general nonlinear. By using this method a pattern of the function that is supposed to fit the data is needed. 
Depending on the estimation from function shape, the pattern may vary from a linear function like y  ax  b to nonlinear 
functions such as  y  m  e45  b. This pattern helps the modelling process to draw a curve by estimating the value of the 
parameters. In the above example, ‘m’, ‘a’ and ‘b’ are parameters of the mentioned functions, while ‘y’ and ‘x’ are dependent 
and independent variables, respectively. For each observation record in the data file, this method executes the pattern and 
computes the value of the function. The computed value of the function is assigned to the variable namely Predicted. The 
predicted value is then subtracted from the actual value of the dependent variable and this difference is assigned to the 
Residual variable. This process is repeated for each observation in the data file and the squared residual values are added 
together. After all of the observations have been processed, the values of the parameters are adjusted and this process is being 
repeated to minimize the sum of the squared residuals (Sherrod 2010).  
Both of these methods create models by using the observed data; the models then are able to get a specific value of HbA1c as 
input and predict the risk of retinopathy for that particular HbA1c Level. 
Artificial neural networks (ANN) and regression analysis are used to create a prediction model based on observed data. 
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Artificial Neural Networks (ANNs) 
Software application Tiberius (Brierley 2011) was used for making predictive models. 
Regression Analysis 
The objective of regression analysis is to determine the best model that can relate the output variable to various input 
variables. More formally, regression analysis is the process of determining how a variable Y is related to one or more other 
variables X1, … Xn. Y is usually called the response output or dependent variable, and Xi-n are inputs, regressors, explanatory 
variables or independent variables. Several software packages exist to solve regression problems. Examples include SAS 
(www.sas.com), NLREG (www.nlreg.com), S-Plus (csan.insightful.com) and SPSS (IBM 2010). This last was the software 
used in this study. 
RESULTS 
Figure 1 shows the neural network made by Tiberius which attempts to reveal the relationship between risk factor values as 
input, and risk percentage of any diabetic complication as output, for all of the records.  
The network tries to make a model that relates the input numbers to the output ones. This model is created in such a way as to 
produce the least amount of error in predicting an output for its respective input. An example of the model produced by the 
software between HbA1c and all kinds of retinopathy is illustrated in Figure 2-4. 
 
 
Figure 1. The neural network which created the model based on the observed data 
 
 
Figure 2: The model made by the neural network (HbA1c-PDR) and (HbA1c –NPDR) 
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Figure 3: The model made by the neural network (duration-PDR) and (duration –NPDR) 
 
 
Figure 4: The model made by the neural network (AER-PDR) and (AER –NPDR) 
 
Table 3 shows the statistical indices of ANN patterns for all dataset tables. 
 
Related data table Std. Error of the Estimate R R Square 
HbA1c-PDR 9.288 .748 .560 
HbA1c-NPDR 9.016 .735 .540 
Dur-PDR 10.522 .792 .628 
Dur-NPDR 9.509 .898 .807 
AER-PDR 6.515 .931 .866 
AER-NPDR 8.657 .741 .549 
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Table 3. The statistical indices of ANN patterns 
 
Regression Analysis  
We provide SPSS with the same dataset. Seven different patterns, i.e. linear, logarithmic, quadratic, cubic, power, s and 
exponential, have been chosen as the best options. 
Then, this application uses the process mentioned in the methodology to determine the value of the parameters. Figure 5, as 
an example, shows the scatter graphs along with plots of the selected best fitted function to the set of data values among all 
seven patterns. 
SPSS calculates the values of parameters for all mentioned patterns to achieve the functions. Table 4-9 show the statistical 
indices of these seven patterns for all dataset tables. The highlighted rows in each table indicate the selected best fitted 
function to the set of data values among all seven patterns.  
 
Models R R Square 
Wherry’s 
Adjusted R 
Square 
Std. Error 
of the 
Estimate 
F-ratio 
F Sig 
Linear .755 .570 .539 9.815 18.537 .001 
Logarithmic .768 .590 .561 9.583 20.136 .001 
Quadratic .776 .602 .541 9.794 9.840 .002 
Cubic .780 .608 .548 9.720 10.089 .002 
Power .764 .584 .555 .799 19.689 .001 
S .793 .628 .602 .756 23.678 < .001 
Exponential .713 .509 .474 .869 14.494 .002 
Table  4. Statistical indices of the selected seven patterns for HbA1c-PDR data tables 
 
Models R R Square 
Wherry’s 
Adjusted R 
Square 
Std. Error 
of the 
Estimate 
F-ratio 
F Sig 
Linear .736 .542 .509 9.616 16.549 .001 
Logarithmic .723 .523 .489 9.808 15.365 .002 
Quadratic .739 .546 .479 9.933 7.817 .006 
Cubic .739 .547 .477 9.925 7.839 .006 
Power .676 .457 .419 .635 11.800 .004 
S .668 .447 .407 .641 11.294 .005 
Exponential .676 .457 .418 .635 11.778 .004 
Table 5.  Statistical indices of the selected seven patterns for HbA1c-NPDR data tables 
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Models R R Square 
Wherry’s 
Adjusted R 
Square 
Std. Error 
of the 
Estimate 
F-ratio 
F Sig 
Linear .799 .639 .630 10.635 67.268 < .001 
Logarithmic .675 .455 .441 13.064 31.761 < .001 
Quadratic .837 .701 .685 9.813 43.312 < .001 
Cubic .840 .706 .682 9.854 28.865 < .001 
Power .779 .606 .596 1.001 58.564 < .001 
S .780 .608 .598 .999 58.899 < .001 
Exponential .706 .499 .486 1.129 37.862 < .001 
Table 6. Statistical indices of the selected seven patterns for Dur-PDR data tables 
 
Models R R Square 
Wherry’s 
Adjusted R 
Square 
Std. Error 
of the 
Estimate 
F-ratio 
F Sig 
Linear .905 .819 .804 9.939 54.420 < .001 
Logarithmic .823 .677 .650 13.287 25.167 < .001 
Quadratic .906 .820 .788 10.351 25.123 < .001 
Cubic .907 .822 .769 10.801 15.416 < .001 
Power .932 .868 .857 .325 79.216 < .001 
S .806 .649 .620 .531 22.204 .001 
Exponential .891 .794 .777 .407 46.193 < .001 
Table 7. Statistical indices of the selected seven patterns for Dur-NPDR data tables 
 
Models R R Square 
Wherry’s 
Adjusted R 
Square 
Std. Error 
of the 
Estimate 
F-ratio 
F Sig 
Linear .932 .870 .860 6.904 86.644 < .001 
Logarithmic .842 .709 .686 10.320 31.603 < .001 
Quadratic .946 .894 .877 6.470 50.736 < .001 
Cubic .962 .926 .906 5.640 46.104 < .001 
Power .908 .825 .812 .371 61.271 < .001 
S .868 .754 .735 .441 39.783 < .001 
Exponential .864 .747 .728 .446 38.413 < .001 
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Table 8. Statistical indices of the selected seven patterns for AER-PDR data tables 
 
Models R R Square 
Wherry’s 
Adjusted R 
Square 
Std. Error 
of the 
Estimate 
F-ratio 
F Sig 
Linear .765 .585 .544 9.091 14.122 .004 
Logarithmic .595 .354 .289 11.349 5.479 .041 
Quadratic .801 .641 .562 8.914 8.043 .010 
Cubic .859 .738 .640 8.083 7.505 .010 
Power .542 .294 .223 .891 4.156 .069 
S .289 .083 -.008 1.015 .909 .363 
Exponential .632 .399 .339 .822 6.650 .027 
Table 9. Statistical indices of the selected seven patterns for AER-NPDR data tables 
 
 
Figure 5. A scatter graph between HbA1c level and risk of PDR and NPDR 
 
We applied the Durbin-Watson test for all dataset tables and all the results were between 1.5 and 2.5, which implies the 
existence of  independent errors (Hutcheson et al. 1999). Then, using R-squared it can be clearly seen that the best selected 
regression models fit the data in all dataset tables better than ANN, as well as other six regression patterns (Table 10). 
For all dataset tables, F is greater than one and also is significant at p < .01, which tells us that there is a less than 1% chance 
that F-ratios this large would happen if the null hypothesis were true. Therefore, we can conclude that our regression models 
result in significantly better prediction of complications than if we used the mean value of complications. 
DISCUSSION AND CONCLUSION 
In order to create 1-1 models, curve fitting was performed by using two different software applications: Tiberius (Brierley 
2011)  and SPSS (IBM 2010),  which work based on ANN and least square regression, respectively. To start producing the 
model, seven different regression patterns, i.e. linear, logarithmic, quadratic, cubic, power, s and exponential, have been 
chosen as the best options. Using R-squared, it can be clearly seen that the best selected regression models fit the data in all 
the dataset tables better than ANN, as well as the other six regression patterns do. We also applied the Durbin-Watson test for 
all the dataset tables and all the results were between 1.5 and 2.5.  This implies the existence of independent errors. In 
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addition, calculation of F-ratio and its associated significant value has been done. For all dataset tables, F is greater than one, 
and is significant at p < .01. 
 
Dataset table 
ANN Best fitted regression patterns 
R2 R2 D-W1 Wherry’s Adj-R2 
Stein’s 
Adj-R2 
F ratio Pattern 
shape F Sig. 
HbA1c-PDR .560 .628 1.923 .602 .544 23.7 < .001 S 
HbA1c-NPDR .540 .542 2.104 .509 .439 16.6 .001 linear 
Dur-PDR .628 .701 1.822 .685 .668 43.3 < .001 quadratic 
Dur-NPDR .807 .868 2.396 .857 .833 79.2 < .001 power 
AER-PDR .866 .926 1.770 .906 .869 46.1 < .001 cubic 
AER-NPDR .549 .585 1.801 .544 .451 14.1 .004 linear 
Table 10: Statistical details of ANN and the best fitted regression models 
 
As mentioned in the methodology section, all of the models are created based on the previously observed relationships which 
are recorded by a number of surveys. In most cases, each relevant article had only one pair of numeric data to quantify an 
individual 1-1 relationship. Searching and finding a large number of articles and surveys which included useful information 
was a difficult part of this research. All of the models are created using the data from diabetic patients. Needless to say, 
models created based on epidemiologic information can be used only for the same population from which we have created 
the models. This simply means that as the data are gathered from diabetic patients, the models can be used to predict the 
complications of patients who already have diabetes. 
As we know, however, each complication is affected by a variety of factors. In order to see the affect of all risk factors on one 
complication, we need to integrate all created models for that specific complication. Therefore, for every one of these factors 
one 1-1 model is created. By integrating these, N-1 model which shows the affect of all the mentioned factors together on the 
risk of retinopathy will be created. Ultimately N-K model of risk factors and the complication will be developed. This will 
indeed assist healthcare providers in focusing complications based on the risk factors. Therefore, this study will have the 
practical implications in healthcare delivery process by providing decision support tool for chronic disease management. 
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